The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis

ConclusionMore nuanced policies are needed to ensure the appropriate access to 25‐mg quetiapine for dose escalation while discouraging use for indications where the evidence of risk and benefit is unclear.

Source: Pharmacoepidemiology and Drug Safety - February 1, 2018 Category: Drugs & Pharmacology Authors: Jonathan Brett, Andrea Schaffer, Timothy Dobbins, Nicholas A. Buckley, Sallie ‐Anne Pearson Tags: ORIGINAL REPORT Source Type: research